Cue BiopharmaCUE
13F holders, Q1 2025 (March 31)49holders −6
7new positions
13sold out
1famous investor
$0.91avg. 13F price*
At the end of Q1 2025, 49 institutions reported holding Cue Biopharma Inc. (CUE) in their 13F filings, down 6 from Q4 2024. 7 opened new positions and 13 sold out. The largest holders were Bleichroeder LP ($4.6M), Vanguard Group Inc. ($2.1M) and Geode Capital Management, LLC ($632K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cue Biopharma Inc.
- CUSIP
- 22978P106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $140K |
| Exits | 13 | $702K |
All 13F filers, Q4 2024 → Q1 2025: 516,496 shares bought and 873,284 shares sold, net −356,788 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 49 holders
| Bleichroeder LP | 1.22% | No change | 4,997,240 | $4.6M |
| Vanguard Group Inc. | 0.00% | Add +12.6% | 2,315,862 | $2.1M |
| Geode Capital Management, LLC | 0.00% | Add +9.9% | 693,890 | $632K |
| BlackRock, Inc. | 0.00% | Reduce -0.6% | 635,203 | $579K |
| Robertson Stephens Wealth Management, LLC | 0.02% | No change | 478,500 | $436K |
| Sigma Planning Corp | 0.01% | Reduce -27.0% | 326,260 | $297K |
| Bank of America Corp. | 0.00% | Add +0.0% | 324,351 | $295K |
| Advisory Research Inc. | 0.04% | No change | 257,225 | $234K |
| Stifel Financial Corp. | 0.00% | Reduce -3.7% | 203,578 | $185K |
| Northern Trust Corp. | 0.00% | Reduce -5.6% | 196,629 | $179K |
| State Street Corp. | 0.00% | No change | 189,753 | $173K |
| HighTower Advisors, LLC | 0.00% | No change | 128,284 | $117K |
| Gsa Capital Partners LLP | 0.01% | Reduce -21.7% | 117,262 | $107K |
| Chicago Partners Investment Group LLC | 0.00% | New | 90,302 | $69K |
| UBS Group AG | 0.00% | Add +5.1% | 61,313 | $56K |
| LPL Financial LLC | 0.00% | Reduce -0.0% | 42,925 | $39K |
| Renaissance Technologies | 0.00% | New | 36,946 | $34K |
| Squarepoint Ops LLC | 0.00% | Add +76.7% | 34,778 | $32K |
| Texas Capital Bank Wealth Management Services Inc | 0.00% | No change | 33,102 | $30K |
| Morgan Stanley | 0.00% | Reduce 0.0% | 28,692 | $26K |
| XTX Topco Ltd | 0.00% | Reduce -42.6% | 26,944 | $25K |
| Navalign, LLC | 0.01% | No change | 25,000 | $23K |
| Wells Fargo & Company | 0.00% | No change | 20,077 | $18K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 20,000 | $18K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -58.3% | 14,401 | $13K |
| StoneX Group Inc. | 0.00% | New | 14,058 | $13K |
| Group One Trading LLC | 0.00% | New | 13,572 | $12K |
| SeaCrest Wealth Management, LLC | 0.00% | No change | 13,000 | $12K |
| Two Sigma Securities, LLC | 0.00% | New | 10,390 | $9K |
| Northwestern Mutual Wealth Management Co. | 0.00% | Add +300.0% | 10,000 | $9K |
| Beacon Pointe Advisors, LLC | 0.00% | No change | 10,000 | $9K |
| Barclays PLC | 0.00% | No change | 6,029 | $5K |
| Gleason Group, Inc. | 0.00% | No change | 6,000 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -63.3% | 3,874 | $4K |
| NFSG Corp | 0.00% | Add +16.7% | 3,500 | $3K |
| NewEdge Advisors, LLC | 0.00% | No change | 2,550 | $2K |
| Simplex Trading, LLC | 0.00% | Reduce -65.3% | 2,395 | $2K |
| Golden State Wealth Management, LLC | 0.00% | No change | 2,000 | $2K |
| Tidemark, LLC | 0.00% | New | 1,500 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -1.0% | 1,051 | $958 |
| Physician Wealth Advisors, Inc. | 0.00% | No change | 1,006 | $917 |
| Mather Group, Llc. | 0.00% | New | 1,000 | $911 |
| BNP Paribas Financial Markets | 0.00% | Reduce -16.3% | 715 | $651 |
| Osaic Holdings, Inc. | 0.00% | Add +79.0% | 680 | $618 |
| MAI Capital Management | 0.00% | No change | 350 | $319 |
| Sunbelt Securities, Inc. | 0.00% | No change | 237 | $216 |
| Armstrong Advisory Group, Inc. | 0.00% | No change | 120 | $131 |
| IFP Advisors, Inc | 0.00% | No change | 100 | $91 |
| Stonebridge Financial Group, LLC | 0.00% | No change | 62 | $56 |
"% of holder's portfolio" is CUE's weight in each manager's 13F, not the share of Cue Biopharma Inc. the manager owns.